Department of Neurobiology
School of Medicine, University of California Irvine
Irvine, California, USA.
Mr. Sharp has more than 15 years of experience in biological sciences with hands-on experience being a bench scientist. He is developing ES cell based therapy for spinal cord injury and other neural diseases. He is an expert of Human ES cell culture. He developed the program of mass production of Human ES cell for therapeutic use. He has expertise in development of cGMP cell culture (e.g., manage IQ/OQ/PQs), Intellectual property management (e.g., compile patents for submission to USPTO), Oversight of pre-clinical/non-clinical studies (e.g., qualify CROs for toxicology studies), Regulatory compliance management (e.g., manage pre-IND discussions), Clinical development (e.g. develop inclusion/exclusion criteria for patients), Business development (e.g., valuation of an in-license candidate).